JGMCX
Price
$22.57
Change
+$0.20 (+0.89%)
Updated
Dec 3 closing price
Net Assets
5.65B
VEXRX
Price
$115.63
Change
+$1.21 (+1.06%)
Updated
Dec 3 closing price
Net Assets
20.54B
Interact to see
Advertisement

JGMCX vs VEXRX

Header iconJGMCX vs VEXRX Comparison
Open Charts JGMCX vs VEXRXBanner chart's image
Janus Henderson Triton C
Price$22.57
Change+$0.20 (+0.89%)
VolumeN/A
Net Assets5.65B
Vanguard Explorer Adm
Price$115.63
Change+$1.21 (+1.06%)
VolumeN/A
Net Assets20.54B
JGMCX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
JGMCX vs. VEXRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGMCX is a Buy and VEXRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.5B vs. JGMCX (5.65B). VEXRX pays higher dividends than JGMCX: VEXRX (0.48) vs JGMCX (0.00). JGMCX was incepted earlier than VEXRX: JGMCX (16 years) vs VEXRX (24 years). JGMCX (1.76) is less costly to investors than VEXRX (0.33). VEXRX is a more actively managed with annual turnover of: 35.00 vs. JGMCX (19.00). JGMCX has a lower initial minimum investment than VEXRX: JGMCX (2500) vs VEXRX (50000). VEXRX annual gain was more profitable for investors over the last year : -6.40 vs. JGMCX (-7.75). VEXRX return over 5 years is better than : -3.51 vs. JGMCX (-31.09).
JGMCXVEXRXJGMCX / VEXRX
Total Expense Ratio1.760.33533%
Annual Report Gross Expense Ratio1.760.33533%
Fund Existence16 years24 years-
Gain YTD8.1647.178114%
Front LoadN/AN/A-
Min. Initial Investment2500500005%
Min. Initial Investment IRAN/AN/A-
Net Assets5.65B20.5B28%
Annual Yield % from dividends0.000.48-
Returns for 1 year-7.75-6.40121%
Returns for 3 years-2.3518.59-13%
Returns for 5 years-31.09-3.51886%
Returns for 10 years-2.6934.86-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBMAX30.70N/A
N/A
BNY Mellon Sm/Md Cp Gr A
LGMAX26.89N/A
N/A
Loomis Sayles Global Allocation A
BIGFX31.33N/A
N/A
Baron International Growth Retail
BCAMX79.92N/A
N/A
Boston Common ESG Impact US Equity
RGLGX28.33N/A
N/A
American Funds Global Insight R-6